Terms: = Ovarian cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Prognosis
95 results:
1. Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer.
Chen L; Fan T; Wang M; Zhu CY; Feng WY; Li Y; Yang H
Expert Opin Ther Targets; 2024; 28(1-2):83-95. PubMed ID: 38235574
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
[TBL] [Abstract] [Full Text] [Related]
3. High-grade serous ovarian carcinoma, the "Achiles' hill" for clinicians and molecular biologists: a molecular insight.
Bhattacharya R; Ghosh A; Mukhopadhyay S
Mol Biol Rep; 2023 Nov; 50(11):9511-9519. PubMed ID: 37737967
[TBL] [Abstract] [Full Text] [Related]
4. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
[TBL] [Abstract] [Full Text] [Related]
5. Current limits of conservative treatment in ovarian cancer.
Gracia M; Alonso-Espías M; Zapardiel I
Curr Opin Oncol; 2023 Sep; 35(5):389-393. PubMed ID: 37498109
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Significance of Methyltransferase-like 16 Expression in Epithelial ovarian cancer.
Li C; Qiao C; Ding H; Luo Y
J Coll Physicians Surg Pak; 2022 Dec; 32(12):1576-1580. PubMed ID: 36474378
[TBL] [Abstract] [Full Text] [Related]
7. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract] [Full Text] [Related]
8. [Évolution des traitements adjuvants des cancers de l'ovaire].
Pautier P
Rev Prat; 2022 Jun; 72(6):633-637. PubMed ID: 35899664
[TBL] [Abstract] [Full Text] [Related]
9. Use of staging for sex cord stromal tumours.
Negri S; Grassi T; Fruscio R
Curr Opin Oncol; 2022 Sep; 34(5):504-510. PubMed ID: 35849655
[TBL] [Abstract] [Full Text] [Related]
10. Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer.
Chalif J; Yao M; Gruner M; Kuznicki M; Vargas R; Rose PG; Michener C; DeBernardo R; Chambers L
Gynecol Oncol; 2022 Apr; 165(1):90-96. PubMed ID: 35272875
[TBL] [Abstract] [Full Text] [Related]
11. Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma.
Cao C; Yu R; Gong W; Liu D; Zhang X; Fang Y; Xia Y; Zhang W; Gao Q
Aging (Albany NY); 2021 Nov; 13(22):24686-24709. PubMed ID: 34837690
[TBL] [Abstract] [Full Text] [Related]
12. Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics.
Wang Z; Zhao S; Shi J; Meng F; Yuan J; Zhong Z
Acta Biomater; 2022 Jan; 138():443-452. PubMed ID: 34757229
[TBL] [Abstract] [Full Text] [Related]
13. Initial Ca 125 Value as a Predictive Marker for High-grade Serous ovarian cancer.
Ay S; Ozyukseler DT; Dulgar O; Basak M; Yildirim ME; Gumus M
J Coll Physicians Surg Pak; 2021 Jun; 31(6):651-656. PubMed ID: 34102775
[TBL] [Abstract] [Full Text] [Related]
14. A broad analysis in clinical and in vitro models on regulator of G-protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance.
Kucuk B; Kibar B; Cacan E
Cell Biochem Funct; 2021 Apr; 39(3):413-422. PubMed ID: 33354811
[TBL] [Abstract] [Full Text] [Related]
15. Impact of ARTs on oncological outcomes in young breast cancer survivors.
Condorelli M; De Vos M; Lie Fong S; Autin C; Delvigne A; Vanden Meerschaut F; Wyns C; Imbert R; Cheruy C; Bouziotis J; de Azambuja E; Delbaere A; Lambertini M; Demeestere I
Hum Reprod; 2021 Jan; 36(2):381-389. PubMed ID: 33289029
[TBL] [Abstract] [Full Text] [Related]
16. The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study.
Vaiarelli A; Cimadomo D; Alviggi E; Sansone A; Trabucco E; Dusi L; Buffo L; Barnocchi N; Fiorini F; Colamaria S; Giuliani M; Argento C; Rienzi L; Ubaldi FM
Hum Reprod; 2020 Nov; 35(11):2598-2608. PubMed ID: 32951051
[TBL] [Abstract] [Full Text] [Related]
17. Circulating CD14
Stenzel AE; Abrams SI; Joseph JM; Goode EL; Tario JD; Wallace PK; Kaur D; Adamson AK; Buas MF; Lugade AA; Laslavic A; Taylor SE; Orr B; Edwards RP; Elishaev E; Odunsi K; Mongiovi JM; Etter JL; Winham SJ; Kaufmann SH; Modugno F; Moysich KB
Am J Reprod Immunol; 2021 Mar; 85(3):e13343. PubMed ID: 32905653
[TBL] [Abstract] [Full Text] [Related]
18. Immunotherapy in gynecological cancers: where are we?
Polastro L; Closset C; Kerger J
Curr Opin Oncol; 2020 Sep; 32(5):459-470. PubMed ID: 32675594
[TBL] [Abstract] [Full Text] [Related]
19. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
20. ovarian tumors in children: how common are lesion recurrence and metachronous disease? A UK CCLG Surgeons cancer Group nationwide study.
Braungart S; ; Craigie RJ; Farrelly P; Losty PD
J Pediatr Surg; 2020 Oct; 55(10):2026-2029. PubMed ID: 31837839
[TBL] [Abstract] [Full Text] [Related]
[Next]
